Futura Medical PLC Investor Presentation on MED2002 (9991J)
July 04 2017 - 1:00AM
UK Regulatory
TIDMFUM
RNS Number : 9991J
Futura Medical PLC
04 July 2017
For immediate release 4 July 2017
Futura Medical plc
("Futura" or the "Company")
Investor Presentation on MED2002
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology, is pleased to announce
that the Company is today presenting to institutional investors on
its topical gel for erectile dysfunction, MED2002.
MED2002 represents a breakthrough treatment for erectile
dysfunction ("ED") with the potential to offer the fastest speed of
onset, the least side-effects and the fewest contra-indications of
any ED medication.
Today's presentation is based on the presentation that Futura
gives to potential licensing partners and comprises a detailed
insight into key aspects of the clinical development and commercial
potential of the product.
The presentation is taking place at noon today at the Surrey
Research Park, where Futura is based, as part of a capital markets
event organised by N+1 Singer, the Company's nominated adviser and
broker.
A copy of the slide deck accompanying the presentation is now
available at the investor section of Futura's website,
www.futuramedical.com.
No new price sensitive information will be disclosed.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0)1483 685
670
mail to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0)20 7466 5000
/ Stephanie Watson
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCRJMLTMBBMBLR
(END) Dow Jones Newswires
July 04, 2017 02:00 ET (06:00 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024